1. Hormone receptors status: a strong determinant of the kinetics of brain metastases occurrence compared with HER2 status in breast cancer
   Amélie Darlix et al, 2018, J Neurooncol CrossRef
2. Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases
   Neal Shah et al, 2018, Pharmacological Research CrossRef
3. External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experience
   Gaia Griguolo et al, 2018, The Breast CrossRef
4. Exosomes: A Promising Avenue for the Diagnosis of Breast Cancer
   Yiming Meng et al, 2019, Technol Cancer Res Treat CrossRef
5. Characterization of molecular scores and gene expression signatures in primary breast cancer, local recurrences and brain metastases
   Mariana Bustamante Eduardo et al, 2019, BMC Cancer CrossRef
6. Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2+ve breast cancer metastasis
   Aadya Nagpal et al, 2019, Breast Cancer Res CrossRef
7. Impact of breast cancer cells´ secretome on the brain metastatic niche remodeling
   R Carvalho et al, 2019, Seminars in Cancer Biology CrossRef
8. Treatment and outcomes in patients with central nervous system metastases from breast cancer in the real-life ESME MBC cohort
   David Pasquier et al, 2020, European Journal of Cancer CrossRef
9. Nanoparticles containing a combination of a drug and an antibody for the treatment of breast cancer brain metastases
   Emily A. Wyatt et al, 2020, Mol. Pharmaceutics CrossRef
10. Heterogeneity and vascular permeability of breast cancer brain metastases
    Maria V. Babak et al, 2020, Cancer Letters CrossRef
11. Brain metastases from breast cancer
    Joana Santos et al, 2020, Clinical Neurology and Neurosurgery CrossRef
12. Identification of ALDH1A3 as a Viable Therapeutic Target in Breast Cancer Metastasis-Initiating Cells.
    Daisuke Yamashita et al, 2020, Mol Cancer Ther CrossRef
13. "Triple-Negative Breast Cancer Central Nervous System Metastases From the Laboratory to the Clinic".
    Alexandra S Zimmer, 2021, Cancer J CrossRef
14. The current status of cancer survivorship care and a consideration of appropriate care model in Korea
    Hye Mi Ko et al, 2020, Korean J Clin Oncol CrossRef
15. Anti-EGFR VHH-armed death receptor ligand–engineered allogeneic stem cells have therapeutic efficacy in diverse brain metastatic breast cancers
    Yohei Kitamura et al, 2021, Sci. Adv. CrossRef
16. The potential of using eribulin in patients with breast cancer, associated with brain metastasis: the scientific background and the Russian clinical experience
    Irina V Kolyadina et al, 2019, J. Mod. Onco. CrossRef
17. NDRG1 in Aggressive Breast Cancer Progression and Brain Metastasis
    Emilly S Villodre et al, 2021 CrossRef
18. Anti-Hormonal Therapy in Breast Cancer and Its Effect on the Blood-Brain Barrier
    Carolin J. Curtaz et al, 2022, Cancers CrossRef
19. Real-world outcomes among patients with HER2+ metastatic breast cancer with brain metastases
    Kendra DeBusk et al, 2022, JMCP CrossRef
20. The role of the NDRG1 in the pathogenesis and treatment of breast cancer
    Xiao Zhao et al, 2023, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
21. null
    Ana Rita Garcia et al, 2023 CrossRef
22. Targeting HMGA1 contributes to immunotherapy in aggressive breast cancer while suppressing EMT
    Xing Chang et al, 2023, Biochemical Pharmacology CrossRef